Talecris Financial Statements
Talecris Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Talecris Stock Quote & Chart
11/06/09 16:00:00 EST •
NASDAQ •
20.43
•
 +0.3700
•
+1.8445 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Talecris Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.59 | 7.49 | 7.00 |
| Price/Earnings Ratio | -- | 92.59 | 25.45 |
| Price/Book Ratio | (63.29) | 3.46 | 6.74 |
| Price/Cash Flow Ratio | 15.27 | 41.15 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Talecris Financial Ratios
Talecris Competitive Intelligence
| Baxter International | CSL Behring | Grifols | |
|---|---|---|---|
| Annual Sales ($ mil.) | 12,348.0 | 0.0 | 1,147.8 |
| Employees | 48,500 | 5,800 | -- |
| Market Cap ($ mil.) | 33,061.0 | -- | 2,378.9 |
Competitive Landscape
